Could cause temporary or reversible harm; serious harm is unlikely.
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
| Brand name | ZOLOFT |
| Generic name | SERTRALINE HYDROCHLORIDE |
| Active ingredient(s) | SERTRALINE HYDROCHLORIDE |
| Distributed by / for | Roerig Division of Pfizer Inc., NY, NY, 10017 |
| NDC | 0049-4960-30 |
| Full product label | Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30 |
| Recalling firm | Pfizer Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 1972 bottles |
| Recall initiated | 2017-10-20 |
| Report date | 2018-01-10 |
| Recall completed | 2020-06-02 |
| Recall number | D-0151-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | New York NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗